Hisashi Takei, Juan Luiz Coelho-Silva, Cristina Tavares Leal, Adriana Queiroz Arantes Rocha, Thiago Mantello Bianco, Robert S. Welner, Yuta Mishima, Ikei S Kobayashi, Ann Mullally, Keli Lima, et al. Suppression of multiple anti-apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms. Cancer Science. 2021
Shoichi Iriguchi, Yutaka Yasui, Yohei Kawai, Suguru Arima, Mihoko Kunitomo, Takayuki Sato, Tatsuki Ueda, Atsutaka Minagawa, Yuta Mishima, Nariaki Yanagawa, et al. A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy. Nature Communications. 2021. 12. 1
Hiroaki Mashima, Rong Zhang, Tsuyoshi Kobayashi, Yuichiro Hagiya, Hirotake Tsukamoto, Tianyi Liu, Tatsuaki Iwama, Masateru Yamamoto, Chiahsuan Lin, Ryusuke Nakatsuka, et al. Generation of GM-CSF-producing antigen-presenting cells that induce a cytotoxic T cell-mediated antitumor response. OncoImmunology. 2020. 9. 1. 1814620-1814620
Yu-suke Torisawa, Yuta Mishima, Shin Kaneko. Developing thymus-on-a-chip and cancer-on-a-chip for cancer immunotherapy. Impact. 2019
Yuta Mishima, Changshan Wang, Satoru Miyagi, Atsunori Saraya, Hiroyuki Hosokawa, Makiko Mochizuki-Kashio, Yaeko Nakajima-Takagi, Shuhei Koide, Masamitsu Negishi, Goro Sashida, et al. Histone acetylation mediated by Brd1 is crucial for Cd8 gene activation during early thymocyte development. NATURE COMMUNICATIONS. 2014. 5
MODELING CANCER IMMUNOTHERAPY IN A PERFUSABLE 3D VASCULARIZED TUMOR-ON-A-CHIP USING HLA-KO UNIVERSAL HUMAN IPSC-DERIVED ENDOTHELIAL CELLS
(ISSCR 2020 Virtual 2020)
Modeling cancer immunotherapy in a perfusable 3D vascularized tumor-on-a-Chip using universal iPSC-derived endothelial cells.
(CiRA 2019 International Symposium 2019)
